Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2024-06-17 Sale |
2024-06-18 9:27 pm |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
372 | $1.28 | $476 | 23,310 (Direct) |
View |
| 2024-06-17 Sale |
2024-06-18 9:26 pm |
BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer |
244 | $1.2627 | $308 | 11,748 (Direct) |
View |
| 2024-06-17 Sale |
2024-06-18 9:26 pm |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
372 | $1.2622 | $470 | 15,312 (Direct) |
View |
| 2024-06-17 Sale |
2024-06-18 9:25 pm |
BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks |
361 | $1.2632 | $456 | 18,230 (Direct) |
View |
| 2024-06-17 Sale |
2024-06-18 9:25 pm |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks |
155 | $1.285 | $199 | 7,172 (Direct) |
View |
| 2024-06-17 Sale |
2024-06-18 9:24 pm |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President 10% Owner |
2,134 | $1.2835 | $2,739 | 7,791,806 (Indirect Direct) |
View |
| 2024-06-04 Sale |
2024-06-06 8:35 pm |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal BioXcel Holdings Inc. BioXcel LLC CEO and President 10% Owner |
1,427,494 | $0.28381 | $405,135 | 7,731,185 (Indirect Direct) |
View |
| 2024-04-04 Sale |
2024-04-08 7:32 pm |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks |
165 | $2.6211 | $432 | 16,327 (Direct) |
View |
| 2024-04-04 Sale |
2024-04-08 7:32 pm |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
5,268 | $2.624 | $13,823 | 8,655,189 (Indirect Direct) |
View |
| 2024-04-04 Sale |
2024-04-08 7:32 pm |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
1,069 | $2.635 | $2,817 | 15,684 (Direct) |
View |
| 2024-04-04 Sale |
2024-04-08 7:31 pm |
BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. CHIEF COMMERCIAL OFFICER |
1,008 | $2.6351 | $2,656 | 11,992 (Direct) |
View |
| 2024-04-04 Sale |
2024-04-08 7:30 pm |
BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks |
1,012 | $2.6358 | $2,667 | 18,591 (Direct) |
View |
| 2024-04-04 Sale |
2024-04-08 7:30 pm |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
1,067 | $2.635 | $2,812 | 23,682 (Direct) |
View |
| 2023-06-15 Sale |
2023-06-16 6:40 pm |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
60,000 | $20.86 | $1,251,727 | 688,607 (Indirect Direct) |
View |
| 2023-05-22 Sale |
2023-05-24 4:37 pm |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
6,500 | $25.79 | $167,641 | 39,294 (Indirect Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2024-06-14 Exercise |
2024-06-18 9:27 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
1,083 | $0 | 23,310 (Direct) |
View |
| 2024-06-15 Exercise |
2024-06-18 9:26 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. Chief Commercial Officer |
750 | $0 | 11,748 (Direct) |
View |
| 2024-06-14 Exercise |
2024-06-18 9:26 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
1,083 | $0 | 15,312 (Direct) |
View |
| 2024-06-14 Exercise |
2024-06-18 9:25 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks |
1,083 | $0 | 18,230 (Direct) |
View |
| 2024-06-14 Exercise |
2024-06-18 9:25 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks |
521 | $0 | 7,172 (Direct) |
View |
| 2024-06-14 Exercise |
2024-06-18 9:24 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President 10% Owner |
6,109 | $0 | 7,791,806 (Direct) |
View |
| 2024-06-10 Option Award |
2024-06-11 7:02 pm |
N/A 2034-06-10 |
BioXcel Therapeutics Inc. | BTAI | Votruba Michal Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2024-06-10 Other |
2024-06-11 7:02 pm |
N/A 2034-06-10 |
BioXcel Therapeutics Inc. | BTAI | Votruba Michal Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2024-06-10 Option Award |
2024-06-11 7:01 pm |
N/A 2034-06-10 |
BioXcel Therapeutics Inc. | BTAI | Laumas Sandeep Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2024-06-10 Option Award |
2024-06-11 7:01 pm |
N/A 2034-06-10 |
BioXcel Therapeutics Inc. | BTAI | MUELLER PETER Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2024-06-10 Option Award |
2024-06-11 7:00 pm |
N/A 2034-06-10 |
BioXcel Therapeutics Inc. | BTAI | MILLER MICHAEL PATRICK Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2024-06-10 Option Award |
2024-06-11 7:00 pm |
N/A 2034-06-10 |
BioXcel Therapeutics Inc. | BTAI | Bray June Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2024-03-14 Exercise |
2024-04-08 7:32 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent See Remarks |
2,771 | $0 | 16,327 (Direct) |
View |
| 2024-03-14 Exercise |
2024-04-08 7:32 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
16,610 | $0 | 8,655,189 (Direct) |
View |
| 2024-03-14 Exercise |
2024-04-08 7:32 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
2,771 | $0 | 15,684 (Direct) |
View |
| 2024-03-15 Exercise |
2024-04-08 7:31 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Wiley Matthew T. CHIEF COMMERCIAL OFFICER |
3,000 | $0 | 11,992 (Direct) |
View |
| 2024-03-14 Exercise |
2024-04-08 7:30 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks |
2,771 | $0 | 18,591 (Direct) |
View |
| 2024-03-14 Exercise |
2024-04-08 7:30 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
2,771 | $0 | 23,682 (Direct) |
View |
| 2023-12-14 Exercise |
2023-12-18 4:57 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
521 | $0 | 15,749 (Direct) |
View |
| 2023-12-14 Exercise |
2023-12-18 4:55 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
2,609 | $0 | 8,604,457 (Direct) |
View |
| 2023-12-14 Exercise |
2023-12-18 4:54 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks |
521 | $0 | 10,603 (Direct) |
View |
| 2023-12-14 Exercise |
2023-12-18 4:52 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
521 | $0 | 7,753 (Direct) |
View |
| 2023-12-14 Exercise |
2023-12-18 4:47 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer |
521 | $0 | 7,492 (Direct) |
View |
| 2023-09-14 Exercise |
2023-09-18 4:49 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
521 | $0 | 15,749 (Direct) |
View |
| 2023-09-14 Exercise |
2023-09-18 4:49 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
521 | $0 | 7,753 (Direct) |
View |
| 2023-09-14 Exercise |
2023-09-18 4:48 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks |
521 | $0 | 10,603 (Direct) |
View |
| 2023-09-14 Exercise |
2023-09-18 4:47 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer |
521 | $0 | 7,492 (Direct) |
View |
| 2023-09-14 Exercise |
2023-09-18 4:47 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
2,610 | $0 | 57,707 (Direct) |
View |
| 2023-06-26 Option Award |
2023-06-28 5:02 pm |
N/A 2033-06-26 |
BioXcel Therapeutics Inc. | BTAI | Bray June Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2023-06-26 Option Award |
2023-06-28 5:01 pm |
N/A 2033-06-26 |
BioXcel Therapeutics Inc. | BTAI | MUELLER PETER Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2023-06-26 Option Award |
2023-06-28 4:59 pm |
N/A 2033-06-26 |
BioXcel Therapeutics Inc. | BTAI | MILLER MICHAEL PATRICK Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2023-06-26 Option Award |
2023-06-28 4:58 pm |
N/A 2033-06-26 |
BioXcel Therapeutics Inc. | BTAI | Laumas Sandeep Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2023-06-26 Option Award |
2023-06-28 4:56 pm |
N/A 2033-06-26 |
BioXcel Therapeutics Inc. | BTAI | Votruba Michal Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2023-06-26 Other |
2023-06-28 4:56 pm |
N/A 2033-06-26 |
BioXcel Therapeutics Inc. | BTAI | Votruba Michal Director |
17,000 | $0 | 17,000 (Direct) |
View |
| 2023-06-14 Exercise |
2023-06-16 6:46 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Rodriguez Javier See Remarks |
521 | $0 | 10,603 (Direct) |
View |
| 2023-06-14 Exercise |
2023-06-16 6:44 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Yocca Frank Chief Scientific Officer |
521 | $0 | 15,749 (Direct) |
View |
| 2023-06-14 Exercise |
2023-06-16 6:42 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Steinhart Richard I Chief Financial Officer |
521 | $0 | 7,753 (Direct) |
View |
| 2023-06-14 Exercise |
2023-06-16 6:40 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
62,609 | $0 | 688,607 (Direct) |
View |
| 2023-06-15 Exercise |
2023-06-16 6:40 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | Mehta Vimal CEO and President |
60,000 | $0.41 | 688,607 (Direct) |
View |
| 2023-06-14 Exercise |
2023-06-16 6:36 pm |
N/A N/A |
BioXcel Therapeutics Inc. | BTAI | O'Neill Vincent Chief Medical Officer |
521 | $0 | 7,492 (Direct) |
View |